Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy
The present study suggests that soluble sFas, sFasL, sPD1, and sPDL1 levels were apoptosis-related markers with potential predictive value of response to neoadjuvant chemotherapy in patients with TNBC and HER2+ breast cancer.
Authors
- Marcelo Ramos Tejo Salgado
- Carolina de Souza Vasconcelos
- Carlos Eduardo Anunciação (ORCID: https://orcid.org/0000-0001-6732-4673)
- Leuridan Cavalcante Torres (ORCID: https://orcid.org/0000-0003-3517-6615)
- Mário Rino Martins (ORCID: https://orcid.org/0000-0001-8705-8210)
- Denise Viana Sobral
Institutions
- AC Camargo Hospital (BR)
- Hospital de Câncer de Pernambuco (BR)
- Instituto de Medicina Integral Professor Fernando Figueira (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1002/jso.27723
- Citations
- 2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
- Ministério da Saúde